Testing a new medicine for safety in healthy volunteers
Part of Brain & nervous system, Kidney & urinary, Mental health, Women’s health & pregnancy clinical trials.
This study tests a new medicine called KS101 to see if it is safe and how it works in healthy people for the first time. It is a first-in-human trial, meaning this is the first time the drug is given to people, and your health will be closely monitored throughout.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 to 55 years old and in good overall health
- You must weigh at least 50 kg (men) or 45 kg (women) with a body mass index between 18 and 30
- You must not smoke or use nicotine products (no more than 5 cigarettes per month, and you must have quit at least 3 years ago)
- You must be willing to use reliable birth control if you or your partner could become pregnant
- You must be able to attend multiple study visits and follow all study rules, including avoiding certain foods and drinks for a short time
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage trial tests a new medicine called GSM-779690T in healthy volunteers to see how safe it is and how the body handles it. Participating could help determine if the medicine is worth testing in people with certain conditions later.
This trial tests the safety of a new drug called KT-579 in healthy adults. It is the first time this drug is being given to humans. The study will help doctors understand how the drug works in the body and if it is safe.
This study tests a new investigational medicine in healthy adults to see how safe it is and how the body processes it. It is a first-in-human trial, so it is looking for volunteers who are generally well and have normal immune function.
This trial is testing a new drug called NSHO-101 in healthy people to see how the body processes it and if it is safe. It helps researchers learn about the drug before testing it in patients with a condition.
This study tests a new medicine in healthy people to see if it is safe and how the body handles it. Participating could help understand side effects before testing in patients.
This trial tests a new medicine (CKD-339) in healthy people to see how the body processes it and if it is safe. It is an early-stage study that could help develop a treatment for conditions like high blood pressure or heart problems.
Hear when a new Chronic kidney disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.